ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

SEEL Company Profile and Key Details

NASDAQ : SEEL

Seelos Therapeutics, Inc.

$0.37

N/A-

At Close 4:00 PM

Not Actively Trading

56.95

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

SEEL Stock Price Chart

Stock Price Today

Seelos Therapeutics, Inc. (SEEL) stock remained unchanged at -, trading at $0.37 on NASDAQ, unchanged from the previous close of -. The stock opened at -, fluctuating between $0.37 and $0.37 in the recent session.

Stock Snapshot

N/A

Prev. Close

N/A

Open

214.97K

Market Cap

581K

Number of Shares

0.37

Day Low

0.37

Day High

0.001054010938924339

P/E Ratio

63.77%

Free Float in %

351.04

EPS (TTM)

-3.42

Book Value

-2.44

Cash Flow per Share

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 17, 2024	0.25	0.35	0.25	0.25	13.61K
Dec 16, 2024	0.25	0.35	0.25	0.28	7.73K
Dec 13, 2024	0.34	0.34	0.30	0.30	3.42K
Dec 12, 2024	0.34	0.37	0.34	0.34	1.45K
Dec 11, 2024	0.33	0.35	0.33	0.34	2.47K
Dec 10, 2024	0.40	0.41	0.25	0.33	61.87K
Dec 09, 2024	0.42	0.42	0.40	0.40	4.84K
Dec 06, 2024	0.42	0.75	0.42	0.42	3.74K
Dec 05, 2024	0.45	0.45	0.35	0.40	9.09K
Dec 04, 2024	0.37	0.37	0.35	0.35	14.75K
Dec 03, 2024	0.45	0.50	0.35	0.35	18.28K
Dec 02, 2024	0.50	0.50	0.32	0.42	22.14K
Nov 29, 2024	0.33	0.51	0.32	0.50	2.15K
Nov 27, 2024	0.54	0.59	0.31	0.33	8.45K
Nov 26, 2024	0.31	0.37	0.31	0.36	4.33K
Nov 25, 2024	0.30	0.53	0.30	0.31	6.34K
Nov 22, 2024	0.51	0.51	0.27	0.30	10.34K
Nov 21, 2024	0.38	0.50	0.33	0.50	11.84K
Nov 20, 2024	0.39	0.39	0.30	0.38	4.85K
Nov 19, 2024	0.37	0.38	0.20	0.35	10.66K

Contact Details

New York, NY 10022

United States

Website: https://seelostherapeutics.comContact: 646 293 2100

About Company

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current Seelos Therapeutics, Inc. (SEEL) stock price?

Seelos Therapeutics, Inc. (NASDAQ: SEEL) stock price is $0.37 in the last trading session. During the trading session, SEEL stock reached the peak price of $0.37 while $0.37 was the lowest point it dropped to. The percentage change in SEEL stock occurred in the recent session was N/A while the dollar amount for the price change in SEEL stock was -.

SEEL's industry and sector of operation?

The NASDAQ listed SEEL is part of Biotechnology industry that operates in the broader Healthcare sector. Seelos Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SEEL?

Mr. Anthony Marciano
Chief Communications Officer
Ms. Kimberly Farrand
Senior Director of Clinical Devel. & Operations
Dr. Raj Mehra J.D., Ph.D.
Founder, Chairman, Chief Executive Officer & Pres
Gopal Krishna Ph.D.
Head of Manufacturing & Technical Operations
Tim Whitaker M.D.
Chief Medical Officer
Mr. Michael J. Golembiewski
Chief Financial Officer
Ms. Karen Fusaro
Senior Vice President & Head of Clinical Operations

How SEEL did perform over past 52-week?

SEEL's closing price is 0% higher than its 52-week low of $0.37 where as its distance from 52-week high of $0.37 is 0%.

How many employees does SEEL have?

Number of SEEL employees currently stands at 8.

Link for SEEL official website?

Official Website of SEEL is: https://seelostherapeutics.com

How do I contact SEEL?

SEEL could be contacted at phone 646 293 2100 and can also be accessed through its website. SEEL operates from 300 Park Avenue, New York, NY 10022, United States.

How many shares of SEEL are traded daily?

SEEL stock volume for the day was 0 shares. The average number of SEEL shares traded daily for last 3 months was 0.

What is the market cap of SEEL currently?

The market value of SEEL currently stands at $214.97K with its latest stock price at $0.37 and 581K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	8
Beta	1.94
Sales or Revenue	$2.20M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology